Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital

OBJECTIVE: Clozapine remains the most effective intervention for treatment resistant schizophrenia; however, its use is prohibited following neutropenias. We review neutrophil biology as applied to clozapine and describe the strategies to initiate clozapine following neutropenia used in a case serie...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Edward, Higgins, Melanie, Hammer, Barbara, Stephenson, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221694/
https://www.ncbi.nlm.nih.gov/pubmed/34221348
http://dx.doi.org/10.1177/20451253211015070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221694/
https://www.ncbi.nlm.nih.gov/pubmed/34221348
http://dx.doi.org/10.1177/20451253211015070

Ejemplares similares